NVOS

Novo Integrated Sciences Inc

NVOS, USA

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.

https://www.novointegrated.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NVOS
stock
NVOS

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients Zacks Investment Research

Read more →
NVOS
stock
NVOS

Novo Nordisk reduces its U.S. sales team for obesity and diabetes education: Reuters Seeking Alpha

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2024-11-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.00

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

33.58 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very High

15.56 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-17.82 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.18

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 2.87% of the total shares of Novo Integrated Sciences Inc

1.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8595%)

since

2024/09/30

2.

Vanguard Total Stock Mkt Idx Inv

(0.708%)

since

2024/09/30

3.

Fidelity Extended Market Index

(0.4424%)

since

2024/09/30

4.

BlackRock Extended Equity Market K

(0.1713%)

since

2024/09/30

5.

Fidelity Series Total Market Index

(0.1051%)

since

2024/09/30

6.

Fidelity Total Market Index

(0.0984%)

since

2024/09/30

7.

NT Ext Equity Mkt Idx Fd - NL

(0.0829%)

since

2024/09/30

8.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0668%)

since

2024/09/30

9.

Northern Trust Extended Eq Market Idx

(0.0636%)

since

2024/09/30

10.

NT Ext Equity Mkt Idx Fd - L

(0.0636%)

since

2024/09/30

11.

Fidelity Nasdaq Composite Index

(0.053%)

since

2024/09/30

12.

Vanguard U.S. Eq Idx £ Acc

(0.0459%)

since

2024/09/30

13.

Spartan Total Market Index Pool E

(0.041%)

since

2024/09/30

14.

Spartan Extended Market Index Pool E

(0.0371%)

since

2024/09/30

15.

Extended Equity Market Fund M

(0.0217%)

since

2024/09/30

16.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0098%)

since

2024/09/30

17.

State St US Extended Mkt Indx NL Cl C

(0.0018%)

since

2024/09/30

18.

SSgA U.S. Total Market Index Strategy

(0.0008%)

since

2024/06/30

19.

State St US Ttl Mkt Indx SL Cl I

(0.0007%)

since

2024/09/30

20.

Fidelity U.S. Equity Index Ins Trust

(0.0005%)

since

2024/09/30

21.

Advisor Group Holdings, Inc.

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2024-11-30

EPS Actual

0.26

EPS Estimate

0

EPS Difference

0.26

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2024-11-30)

Deep Value
Strong Deep Value(8)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Wide Moat Company(8)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(6)
Value
Undervalued(9)

Income Statement

(Last Updated 2024-11-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2024-11-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2024-11-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.